These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38641047)

  • 1. Exploring the potential of drug repurposing for liver diseases: A comprehensive study.
    Ali FEM; Abdel-Reheim MA; Hassanein EHM; Abd El-Aziz MK; Althagafy HS; Badran KSA
    Life Sci; 2024 Jun; 347():122642. PubMed ID: 38641047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform.
    Hudson ML; Samudrala R
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33925237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing of biologics and biopharmaceuticals.
    Israr J; Alam S; Singh V; Kumar A
    Prog Mol Biol Transl Sci; 2024; 205():277-302. PubMed ID: 38789184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational biology approaches for drug repurposing.
    Waseem T; Rajput TA; Mushtaq MS; Babar MM; Rajadas J
    Prog Mol Biol Transl Sci; 2024; 205():91-109. PubMed ID: 38789189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current approaches in identification of a novel drug targets for drug repurposing.
    Khambhati K; Singh V
    Prog Mol Biol Transl Sci; 2024; 205():213-220. PubMed ID: 38789179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. eRepo-ORP: Exploring the Opportunity Space to Combat Orphan Diseases with Existing Drugs.
    Brylinski M; Naderi M; Govindaraj RG; Lemoine J
    J Mol Biol; 2018 Jul; 430(15):2266-2273. PubMed ID: 29237557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Analytical Review of Computational Drug Repurposing.
    Sadeghi SS; Keyvanpour MR
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):472-488. PubMed ID: 31403439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computationally repurposing drugs for breast cancer subtypes using a network-based approach.
    Firoozbakht F; Rezaeian I; Rueda L; Ngom A
    BMC Bioinformatics; 2022 Apr; 23(1):143. PubMed ID: 35443626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing Drug Repurposing for Exploration of New Diseases: An Insight to Strategies and Case Studies.
    Jain P; Jain SK; Jain M
    Curr Mol Med; 2021; 21(2):111-132. PubMed ID: 32560606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
    Turanli B; Gulfidan G; Arga KY
    OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug repurposing: a promising tool to accelerate the drug discovery process.
    Parvathaneni V; Kulkarni NS; Muth A; Gupta V
    Drug Discov Today; 2019 Oct; 24(10):2076-2085. PubMed ID: 31238113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
    Wang Y; Yella J; Jegga AG
    Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a Pipeline Using Disease-Disease Associations for Computational Drug Repurposing.
    Balasundaram P; Kanagavelu R; James N; Maiti S; Veerappapillai S; Karuppaswamy R
    Methods Mol Biol; 2019; 1903():129-148. PubMed ID: 30547440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
    Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
    Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
    Karatzas E; Kolios G; Spyrou GM
    Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The search for disease-modifying agents in decompensated cirrhosis: From drug repurposing to drug discovery.
    Caraceni P; Abraldes JG; Ginès P; Newsome PN; Sarin SK
    J Hepatol; 2021 Jul; 75 Suppl 1():S118-S134. PubMed ID: 34039483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting Repurposing.
    Sharlow ER
    Assay Drug Dev Technol; 2016 Dec; 14(10):554-556. PubMed ID: 27982703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Data-driven drug discovery for drug repurposing].
    Saito R; Yano N; Kojima S; Miyoshi F
    Nihon Yakurigaku Zasshi; 2023; 158(1):10-14. PubMed ID: 36596476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Web-based drug repurposing tools: a survey.
    Sam E; Athri P
    Brief Bioinform; 2019 Jan; 20(1):299-316. PubMed ID: 29028878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.